Most cited papers from COPD Foundation

COPD Foundation

What are the most cited papers from COPD Foundation?

The most cited paper from COPD Foundation is "Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals" (David J. Lederer et al., 2018), with 734 citations. Next come "Genetic diversity fuels gene discovery for tobacco and alcohol use" (532) and "Improving lung health in low-income and middle-income countries: from challenges to solutions" (496).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 59 papers. Every paper with more than 34 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals David J. Lederer et al. · Annals of the American Thoracic Society Open access	19 Sep 2018	734
2	Genetic diversity fuels gene discovery for tobacco and alcohol use Gretchen Saunders et al. · Nature Open access218 authors	7 Dec 2022	532
3	Improving lung health in low-income and middle-income countries: from challenges to solutions Jamilah Z Meghji et al. · The Lancet Open access	23 Feb 2021	496
4	Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review Adam J. Shapiro, Maimoona A. Zariwala, Thomas W. Ferkol et al. · Pediatric Pulmonology Open access	29 Sep 2015	466
5	Eulerian–Lagrangian method for three-dimensional thermal reacting flow with application to coal gasifiers Dale M. Snider, Samuel M. Clark, Peter J. O'Rourke · Chemical Engineering Science	4 Jan 2011	452
6	An improved collision damping time for MP-PIC calculations of dense particle flows with applications to polydisperse sedimenting beds and colliding particle jets Peter J. O'Rourke, Dale M. Snider · Chemical Engineering Science	3 Sep 2010	219
7	Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk Nick R. G. Shrine et al. · Nature Genetics Open access195 authors	Mar 2023	208
8	An official American Thoracic Society/European Respiratory Society statement: research questions in COPD Bartolomé R. Celli et al. · European Respiratory Journal Open access	31 Mar 2015	204
9	COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease Katherine Lowe et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation Open access112 authors	2019	183
10	Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre–Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward Fernando J. Martinez et al. · American Journal of Respiratory and Critical Care Medicine Open access	21 Oct 2021	166
11	A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease Fernando J. Martínez, David M. Mannino, Nancy Kline Leidy et al. · American Journal of Respiratory and Critical Care Medicine Open access	26 Oct 2016	157
12	The 6-Minute-Walk Distance Test as a Chronic Obstructive Pulmonary Disease Stratification Tool: Insights from the COPD Biomarker Qualification Consortium Bartolomé R. Celli, Kay Tetzlaff, Gerard J. Criner et al. · American Journal of Respiratory and Critical Care Medicine Open access	22 Jun 2016	139
13	Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians Gregory David Salinas, Chad R. Williamson, Ravi Kalhan et al. · International Journal of COPD Open access	Feb 2011	138
14	Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease: Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium Bruce E. Miller, Ruth Tal‐Singer, Stephen I. Rennard et al. · American Journal of Respiratory and Critical Care Medicine	8 Jan 2016	129
15	National and State Estimates of COPD Morbidity and Mortality — United States, 2014-2015 Jamie B. Sullivan, Vira Pravosud, David M. Mannino et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation Open access	2018	125
16	Inclusion of collisional return-to-isotropy in the MP-PIC method Peter J. O'Rourke, Dale M. Snider · Chemical Engineering Science	13 Jun 2012	123
17	Integrative “Omic” Analysis of Experimental Bacteremia Identifies a Metabolic Signature That Distinguishes Human Sepsis from Systemic Inflammatory Response Syndromes Raymond J. Langley et al. · American Journal of Respiratory and Critical Care Medicine Open access	23 Jul 2014	115
18	Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective MeiLan King Han et al. · The Lancet Respiratory Medicine	13 May 2016	107
19	Interventions to Reduce Rehospitalizations after Chronic Obstructive Pulmonary Disease Exacerbations. A Systematic Review Valentin Prieto-Centurion, Michael A. Markos, Norma I. Ramey et al. · Annals of the American Thoracic Society ReviewOpen access	14 Feb 2014	107
20	Heterogeneous gas chemistry in the CPFD Eulerian–Lagrangian numerical scheme (ozone decomposition) Dale M. Snider, Sibashis S. Banerjee · Powder Technology	12 Jun 2009	106
21	Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease Dave Singh, Mona Bafadhel, Christopher Edward Brightling et al. · American Journal of Respiratory and Critical Care Medicine Open access	18 Mar 2020	105
22	Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD David M. Mannino, Ruth Tal‐Singer, David A. Lomas et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation Open access	2014	105
23	Benefits of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis Jeffrey J. Swigris, Diane L. Fairclough, Marianne Morrison et al. · Respiratory Care Open access	Jun 2011	104
24	Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts Peter J. Castaldi et al. · Thorax Open access	21 Jun 2017	97
25	Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical Activity Heleen Demeyer et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation Open access	2021	95
26	Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease Weijie Liang et al. · Cell Host & Microbe Open access	18 May 2023	90
27	Whoever shouts the loudest: Listening to parents of children with disabilities Christian Ryan, Elizabeth M. Quinlan · Journal of Applied Research in Intellectual Disabilities	12 Apr 2017	88
28	Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop Report Emily M. Henkle, Timothy R. Aksamit, ALAN ROBERT BARKER et al. · Annals of the American Thoracic Society Open access	Sep 2016	79
29	Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies Laura Ann Adang et al. · Molecular Genetics and Metabolism Open access	20 Aug 2017	74
30	Sulfatide Analysis by Mass Spectrometry for Screening of Metachromatic Leukodystrophy in Dried Blood and Urine Samples Zdeněk Spáčil, Arun Babu Kumar, Hsuan-Chieh Liao et al. · Clinical Chemistry Open access	30 Dec 2015	74
31	Toward newborn screening of metachromatic leukodystrophy: results from analysis of over 27,000 newborn dried blood spots Xinying Hong, Jessica Daiker, Martin Sadı́lek et al. · Genetics in Medicine Open access	19 Nov 2020	73
32	The COPD Biomarker Qualification Consortium (CBQC) Richard H. Casaburi, Bartolomé R. Celli, James D. Crapo et al. · COPD Journal of Chronic Obstructive Pulmonary Disease Open access	28 May 2013	73
33	A new blended acceleration model for the particle contact forces induced by an interstitial fluid in dense particle/fluid flows Peter J. O'Rourke, Dale M. Snider · Powder Technology	7 Feb 2014	68
34	SOX5 Is a Candidate Gene for Chronic Obstructive Pulmonary Disease Susceptibility and Is Necessary for Lung Development Craig P. Hersh, Edwin K. Silverman, Jody L. Gascon et al. · American Journal of Respiratory and Critical Care Medicine Open access	17 Feb 2011	64
35	Relationship between Emphysema Progression at CT and Mortality in Ever-Smokers: Results from the COPDGene and ECLIPSE Cohorts Samuel Y. Ash, Raúl San Jośe Estépar, Sean B. Fain et al. · Radiology Open access	16 Feb 2021	63
36	GOLD in Practice: Chronic Obstructive Pulmonary Disease Treatment and Management in the Primary Care Setting Barbara P. Yawn, Matthew L. Mintz, Dennis E. Doherty · International Journal of COPD Open access	Feb 2021	60
37	Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD Katherine Pratte et al. · Respiratory Research Open access	27 Apr 2021	58
38	The National Patient-Centered Clinical Research Network (PCORnet) Bariatric Study Cohort: Rationale, Methods, and Baseline Characteristics Sengwee Toh, Laura J. Rasmussen‐Torvik, Emily E Harmata et al. · JMIR Research Protocols Open access	5 Dec 2017	58
39	Introducing the COPD Foundation Guide for Diagnosis and Management of COPD, Recommendations of the COPD Foundation Stephen I. Rennard, Byron M. Thomashow, James D. Crapo et al. · COPD Journal of Chronic Obstructive Pulmonary Disease Open access	28 May 2013	58
40	The prevalence and mortality risks of PRISm and COPD in the United States from NHANES 2007–2012 Christopher J. Cadham, Hayoung Oh, MeiLan King Han et al. · Respiratory Research Open access	15 May 2024	57
41	Disease specific therapies in leukodystrophies and leukoencephalopathies Guy Helman et al. · Molecular Genetics and Metabolism Open access	7 Feb 2015	56
42	Complex care of individuals with multiple sulfatase deficiency: Clinical cases and consensus statement Rebecca C. Ahrens‐Nicklas, Lars Schlotawa, Andrea Ballabio et al. · Molecular Genetics and Metabolism Open access	30 Jan 2018	54
43	National and Local Direct Medical Cost Burden of COPD in the United States From 2016 to 2019 and Projections Through 2029 David M. Mannino, Melissa H. Roberts, Douglas W. Mapel et al. · CHEST Journal Open access	30 Nov 2023	53
44	Identifying Patients with Undiagnosed COPD in Primary Care Settings: Insight from Screening Tools and Epidemiologic Studies MeiLan K. Han, Anna W. Steenrod, Elizabeth Dansie Bacci et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation Open access	2014	52
45	Airway Clearance Techniques in Bronchiectasis Ashwin Basavaraj et al. · CHEST Journal Open access	2 Jul 2020	51
46	Questionnaires and Pocket Spirometers Provide an Alternative Approach for COPD Screening in the General Population Steven B. Nelson, Lisa Morrissey LaVange, Yonghong Nie et al. · CHEST Journal Open access	22 Dec 2011	51
47	Small airways obstruction and its risk factors in the Burden of Obstructive Lung Disease (BOLD) study: a multinational cross-sectional study Ben Knox‐Brown et al. · The Lancet Global Health Open access	13 Dec 2022	48
48	Consensus statement on preventive and symptomatic care of leukodystrophy patients Keith P. van Haren, Joshua L. Bonkowsky, Geneviève Bernard et al. · Molecular Genetics and Metabolism	27 Dec 2014	48
49	Antioxidant Amelioration of Riboflavin Transporter Deficiency in Motoneurons Derived from Patient-Specific Induced Pluripotent Stem Cells Chiara Marioli, Valentina Magliocca, Stefania Petrini et al. · International Journal of Molecular Sciences Open access	7 Oct 2020	47
50	Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis Emily M. Henkle et al. · CHEST Journal Open access	5 May 2017	47

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.